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1. INTRODUCTION {#emp212239-sec-0050}
===============

1.1. Background {#emp212239-sec-0060}
---------------

Severe coronavirus disease 2019 (COVID‐19) infections require admissions into emergency departments and critical care units, and despite invasive mechanical ventilation they have high mortality rates.[^1^](#emp212239-bib-0001){ref-type="ref"}, [^2^](#emp212239-bib-0002){ref-type="ref"} When deep hypoxemia appears there is an increased need of prone position ventilation as a rescue maneuver.[^3^](#emp212239-bib-0003){ref-type="ref"} In these critically ill patients, it is necessary to perform repeated and adequate cardiac and hemodynamic evaluation because acute instability can appear suddenly during prone position ventilation.

1.2. Importance {#emp212239-sec-0070}
---------------

Many societies provided their recommendations for conventional echocardiographic evaluation,[^4^](#emp212239-bib-0004){ref-type="ref"} but there is a lack of information on how to obtain images during the prone position ventilation. Transthoracic echocardiography (TTE) in the supine position is the ideal method; however, in those patients for whom returning to supine position is not feasible, this should not be a limitation to perform an echocardiographic evaluation. Therefore, we propose an echocardiographic technique applied in 15 mechanically ventilated patients in prone position during COVID‐19 pandemic performed in our critical care unit.

1.3. Goals of this investigation {#emp212239-sec-0080}
--------------------------------

Our objective was to show the feasibility of obtaining echocardiographic images to measure multiple parameters with TTE during the prone position ventilation.

2. METHODS {#emp212239-sec-0090}
==========

2.1. Study design and setting {#emp212239-sec-0100}
-----------------------------

Cross‐sectional study performed in our critical care unit from April 1, 2020 to May 15, 2020.

2.2. Selection of participants {#emp212239-sec-0110}
------------------------------

We enrolled 15 consecutive mechanically ventilated patients with confirmed severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection that required prone position ventilation as a rescue maneuver for refractory hypoxemia; none were excluded.

2.3. Interventions {#emp212239-sec-0120}
------------------

Transthoracic echocardiograms in prone position were performed by 2 critical care specialists with training in critical care echocardiographic image acquisition. The echocardiographic views and parameters were recorded and measured according to the guidelines of the American Society of Echocardiography to perform a comprehensive transthoracic echocardiographic examination in adults and the guidelines of the American Society of Echocardiography and the European Association of Cardiovascular Imaging for cardiac chamber quantification.[^5^](#emp212239-bib-0005){ref-type="ref"}, [^6^](#emp212239-bib-0006){ref-type="ref"} The following measures were applied to minimize the exposure of the staff to the infection: (1) all studies were performed during regular patient rounds; (2) the machine and sector probe were sanitized adequately after each evaluation; (3) all physicians had adequate personal protective equipment; (4) image measurements were performed outside the patient\'s room and (5) analysis and registration of the measurements were performed by other physicians (3 cardiologists with training in echocardiography --EGC, ALMO and RJAA‐); each reviewed the images from the 15 patients.

### The Bottom Line {#emp212239-sec-0130}

The use of prone positioning during mechanical ventilation has increased during the COVID‐19 pandemic, but it is unknown whether transthoracic echocardiographic views can be obtained in prone patients by physicians trained in point‐of‐care ultrasound. This case series demonstrates that complete apical 4‐ and 5‐chamber views and related measurements were feasible in 14 of 15 prone patients.

2.4. Proposal of echocardiographic technique during the prone position ventilation {#emp212239-sec-0140}
----------------------------------------------------------------------------------

Raise the patient\'s left arm and place a pillow or a folded sheet underneath the mid‐thoracic wall to maintain the left hemithorax slightly elevated for a comfortable transducer manipulation (Figure [1A](#emp212239-fig-0001){ref-type="fig"}).Using a 2--3 mHz phased array sector probe, the operator should obtain the images with the right hand on the right side of the bed (where the left side of the patient lays closer). The probe should be placed in the 5th‐6th intercostal space at mid‐clavicular line (or at the point of maximal apical impulse if palpable), where the conventional apical 4‐chamber view is usually obtained, with the notch pointing to the patient\'s back (Figure [1B](#emp212239-fig-0001){ref-type="fig"}).Tilting, sliding, and "rocking" the probe helps to optimize image resolution (Figure 1C and [1D](#emp212239-fig-0001){ref-type="fig"}). The operator should visualize the same anatomic structures as in a conventional apical 4‐chamber view (Figure [2A](#emp212239-fig-0002){ref-type="fig"}). By tilting the transducer in the direction of the patient\'s abdominal wall, an apical 5‐chamber view can be obtained (Figure 1E and [1F](#emp212239-fig-0001){ref-type="fig"}). The apical views in the prone position were obtained in ≈5 minutes.

![Performing an echocardiogram on a human model in prone position. See text for explanation of the position and measurements](EMP2-9999-na-g002){#emp212239-fig-0001}

![Evaluation of right and left ventricular function in mechanically ventilated patients in prone position. **Panel A**: Apical 4‐chamber view. **Panel B**: right ventricle/left ventricle ratio. **Panel C**: tricuspid peak systolic S wave tissue Doppler velocity (S wave).**Panel D**: tricuspid annular plane systolic excursion (TAPSE). **Panel E**: left ventricular outflow tract velocity integral time (LVOT VTI). **Panel F**: mitral annular plane systolic excursion (MAPSE). **Panel G**: E velocity of mitral inflow filling pattern. **Panel H**: lateral e′ velocity](EMP2-9999-na-g003){#emp212239-fig-0002}

2.5. Measurements {#emp212239-sec-0150}
-----------------

After image acquisition, the following measurements could be obtained in 10 minutes: Evaluation of right ventricular function: right ventricle (RV) basal diameter and RV/left ventricular (LV) ratio, tricuspid peak systolic S wave tissue Doppler velocity (S wave), and tricuspid annular plane systolic excursion (TAPSE) (Figure 2B, 2C and [2D](#emp212239-fig-0002){ref-type="fig"}).Evaluation of left ventricular function: left ventricular outflow tract velocity time integral (LVOT VTI) (Figure [2E](#emp212239-fig-0002){ref-type="fig"}) (and its variation for predicting fluid responsiveness), qualitative LV systolic function; regional wall motion (inferoseptal and anterolateral walls), and mitral annular plane systolic excursion (MAPSE) (Figure [2F](#emp212239-fig-0002){ref-type="fig"}).Evaluation of diastolic function: mitral inflow filling pattern (Figure [2G](#emp212239-fig-0002){ref-type="fig"}) and E/e′ ratio (Figure [2H](#emp212239-fig-0002){ref-type="fig"}).Others: abnormal flow patterns at mitral, tricuspid and/or aortic valves with color Doppler and searching for pericardial effusion.

2.6. Outcomes {#emp212239-sec-0160}
-------------

Feasibility of obtaining echocardiographic images in order to measure parameters with TTE during the prone position ventilation.

2.7. Analysis {#emp212239-sec-0170}
-------------

We performed a descriptive analysis of the measurements in each patient; in order to know the values of the whole population we reported the mean value in the secondary results section. We assessed the interrater reliability for image interpretation using a kappa coefficient among the 3 interpretations of the categorical echocardiographic variables.

3. RESULTS {#emp212239-sec-0180}
==========

3.1. Characteristics of study subjects {#emp212239-sec-0190}
--------------------------------------

In Table [1](#emp212239-tbl-0001){ref-type="table"}, demographic characteristics, comorbidities, symptoms at admission, chest X‐ray, oxygenation index, and treatment are shown. The echocardiographic measurements of the 15 patients evaluated with this technique are described in Table [2](#emp212239-tbl-0002){ref-type="table"}. Patients are labeled as **P1** to **P15** in tables.

###### 

Patients clinical characteristics

  Case   BMI    Age   Comorbidities                                                  Presenting symptoms                            Chest X‐ray                                                             paFiO~2~   IOT‐ Prono time   Treatment
  ------ ------ ----- -------------------------------------------------------------- ---------------------------------------------- ----------------------------------------------------------------------- ---------- ----------------- -----------------------------------------------------------------------------------------------------------------------------------
  1      29.1   39    Overweight                                                     Diarrhea, fever, dry cough, and dyspnea        Bilateral ground‐glass opacification                                    67         24h               Lung protective and prone position ventilation vasopressors, steroids, broad‐spectrum antibiotics, antiviral and anticoagulation.
  2      28.3   66    Overweight and type 2 diabetes                                 Arthralgias, fever and dyspnea                 Cardiomegaly and patchy peripheral left mid to lower lung opacities     80         24h               Lung protective and prone position ventilation, antiviral and anticoagulation
  3      24.5   56    Smoking                                                        Odynophagia and dyspnea                        Diffuse interstitial involvement, predominantly peripheral              111        72h               Lung protective and prone position ventilation, antiviral, systemic steroids, and anticoagulation
  4      33.1   50    Obesity                                                        Odynophagia, fever, and dyspnea                Severe interstitial thickening at lower lobes                           91         48h               Lung protective and prone position ventilation, lopinavir/ritonavir, systemic steroids, and anticoagulation
  5      32.4   63    Overweight, gout, and dyslipidemia                             Dry cough, odynophagia fever, and dyspnea      Ground‐glass opacification at lung bases                                93         12h               Lung protective and prone position ventilation, hydroxychloroquine, azithromycin, anticoagulation, steroids, and hemodialysis
  6      35.1   64    Obesity                                                        Arthralgias, odynophagia, fever, and dyspnea   Severe peripheral interstitial involvementpredominantlyat lower lobes   52         6h                Lung protective and prone position ventilation, systemic steroids, and hemodialysis
  7      24.9   64    Type 2 diabetes and hypertension                               Lipothymy, AV block, and fever                 Peripheralbilateral ground‐glass opacification                          76         72h               Lung protective and prone position ventilation, antiviral, systemic steroids, and anticoagulation
  8      31.1   79    Obesity, type 2 diabetes, and hypertension                     Arthralgia, odynophagia, fever, and dyspnea    Diffuse interstitial involvement, predominantly peripheral              111        48h               Lung protective and prone position ventilation, antiviral, systemic steroids, and anticoagulation
  9      36.3   50    Obesity, hypertension, hyperuricemia, gout, and dyslipidemia   Odynophagia fever and dyspnea severe           Diffuse ground glass opacities predominantly at lung bases              96         5 days            Lung protective and prone position ventilation, systemic steroids, and hemodialysis
  10     24.4   71    Hypertension, dyslipidemia, and ischemic heart disease         Dry cough, fever, and dyspnea                  Cardiomegaly and bilateral ground‐glass opacification                   53         72h               Lung protective and prone position ventilation, antiviral and anticoagulation
  11     23.6   70    Type 2 diabetes                                                Dry cough, fever, and dyspnea                  Peripheral interstitial involvement and right basal consolidation       85         12h               Lung protective and prone position ventilation, hydroxychloroquine, azithromycin, and anticoagulation
  12     30.2   52    Obesity                                                        Dry cough, fever, and dyspnea                  Severe interstitial involvement predominantly in lung bases             65         8h                Lung protective and prone position ventilation, antiviral, and anticoagulation
  13     22.9   66    Type 2 diabetes                                                Asthenia, fever, and dyspnea                   Severe interstitial involvement predominantly peripheral                79         48h               Lung protective and prone position ventilation, systemic steroids, antiviral, and anticoagulation
  14     24.1   69    Alcoholism                                                     Dry cough, fever, and dyspnea                  Diffuse interstitial involvement                                        66         12h               Lung protective and prone position ventilation, antiviral, and anticoagulation
  15     34.4   57    Obesity                                                        Productive cough, fever, and dyspnea           Bilateral diffuse ground‐glass opacities                                100        4h                Lung protective and prone position ventilation, antiviral, and anticoagulation
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###### 

Echocardiographic measurements during the prone position ventilation

  Patient (P)   TAPSE   S′ wave   RV basal diameter   RV/LV ratio   LVOT VTI   LVOT VTI variability   LVF   E/e´   MAPSE   PE
  ------------- ------- --------- ------------------- ------------- ---------- ---------------------- ----- ------ ------- ----
  1             21      13        41                  0.8           17         NO                     N     11     14      NO
  2             23      13        40                  0.7           15         YES                    MR    5      12      NO
  3             NA      NA        NA                  NA            23         NO                     MR    5      11      NO
  4             18      14        38                  0.7           23         NO                     N     10     18      NO
  5             18      13        40                  0.8           16         NO                     N     8      13      NO
  6             23      11        41                  0.9           25         YES                    N     9      17      NO
  7             19      15        43                  0.9           18         NO                     MR    12     11      NO
  8             27      19        39                  0.8           19         NO                     N     8      15      NO
  9             22      11        35                  0.85          17         NO                     N     13     13.5    NO
  10            14      9         37                  0.8           13         NO                     MR    15     9       NO
  11            13      8         35                  0.7           13         YES                    MR    16     9       NO
  12            16      11        39                  0.8           17         NO                     N     10     14      NO
  13            18      9         43                  0.9           14         NO                     MR    10     10      NO
  14            18      14        39                  0.8           15         YES                    N     5      15      NO
  15            17      13        40                  0.9           15         NO                     N     8      13      NO

LV, left ventricular; LVF, left ventricular qualitative systolic function; LVOT, left ventricular outflow tract; MAPSE, mitral annular plane systolic excursion; MR, moderately reduced); N, normal; NA, not available; PE, pericardial effusion; RV, right ventricular; S wave, tricuspid peak systolic S wave tissue Doppler velocity; TAPSE, tricuspid annular plane systolic excursion; VTI, velocity‐time integral.

Normal values: TAPSE ≥17 mm, S wave ≥9.5 cm/s, RV basal diameter \<42 mm, RV/LV ratio \<1, LVOT VTI 18--22 cm, LVOT VTI variability ≥ 12%, MAPSE ≥13 mm.
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3.2. Main results {#emp212239-sec-0200}
-----------------

An adequate evaluation of LV function, diastolic function, valves (mitral, tricuspid, and aortic), and pericardium was possible in 14 of 15 patients. In 1 patient, the RV free wall was unable to be assessed.

3.3. Secondary results {#emp212239-sec-0210}
----------------------

The mean TAPSE was 17.8 mm, the RV S wave 11.5 cm/s, and RV basal diameter 36.6 mm. RV/LV ratio was \<1 in all patients. Four patients had LV VTI variability, which suggested fluid responsiveness. There was a moderate decrease in LV qualitative function in 6 patients that correlated with a low MAPSE (\<13 mm). Pericardial effusion or valvular abnormalities were not observed in any patient. Using a kappa‐coefficient, agreement between raters was \>0.8 for all categorical measurements.

4. LIMITATIONS {#emp212239-sec-0220}
==============

There are some limitations that should be considered in the interpretation of our results. We have to mention that we included consecutive patients with no other selection criteria other than IMV in prone position; therefore, there can be a selection bias. Also in the apical view, the inferior vena cava cannot be evaluated. Finally, this is a preliminary report of the application of a novel technique and it should be validated in other centers.

5. DISCUSSION {#emp212239-sec-0230}
=============

Critical care echocardiography has rapidly evolved as the election technique in the evaluation of the critically ill patients during the COVID‐19 pandemic. These patients have deep hypoxemia and when it cannot be reversed with conventional maneuvers, rescue therapies must be implemented, particularly prone position ventilation, which is indicated when the paO~2~/FiO~2~ ratio is lower than 150 after positive end‐expiratory pressure (PEEP) titration. This technique produces an improvement in oxygenation by increasing the ventilation/perfusion ratio in the dependent lung regions.[^7^](#emp212239-bib-0007){ref-type="ref"} This is particularly relevant because acute respiratory distress syndrome (ARDS) is a major complication of COVID‐19 that occurs in 20%--41% of patients with severe disease.[^8^](#emp212239-bib-0008){ref-type="ref"} Prone position ventilation is the mainstay of treatment in COVID‐19‐related ARDS and has been recommended in the Surviving Sepsis Campaign COVID‐19 guidelines.[^9^](#emp212239-bib-0009){ref-type="ref"} This strategy has been used in as many as 27% of ventilated patients,[^10^](#emp212239-bib-0010){ref-type="ref"} although before the pandemic, it was used in just 8% of patients with ARDS.[^11^](#emp212239-bib-0011){ref-type="ref"}

In our study, we were able to perform TTE in mechanically ventilated patients in prone position without technical difficulties. There are anecdotic reports of TTE[^12^](#emp212239-bib-0012){ref-type="ref"} and a more extensive experience in transesophageal echocardiography during prone position ventilation,[^13^](#emp212239-bib-0013){ref-type="ref"} but there is no standardization in the technique for image acquisition and measurements. Santos et al showed an adequate correlation of the RV measurements in prone compared with the supine position in 50 individuals; however, in this study, the evaluation was in healthy patients, not mechanically ventilated,[^14^](#emp212239-bib-0014){ref-type="ref"} and the performance of critical care echocardiography in patients under IMV has unique challenges because the positive pressure caused by the pulmonary insuflation limits the acoustic window.

We demonstrated the feasibility to obtain an apical 4‐chamber and 5‐chamber views to measure multiple echocardiographic parameters with TTE to perform a qualitative and quantitative evaluation in patients with IMV and prone positioning. During prone position ventilation the patient can develop sudden hemodynamic instability without the possibility to return the patient to the supine position because of the risk to develop refractory hypoxemia, therefore highlighting the need to perform the TTE in prone position. A larger series will be required to assess its correlation with the usual measurements in supine position and its impact in clinical decisionmaking and outcomes. This evaluation can help the physician make a better assessment of the heart‐lung interactions during IMV and this could help to improve patient\'s outcomes.
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